Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
NRC 
National Research Corp (NRC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/15/2025: NRC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -12.79% | Avg. Invested days 24 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 379.83M USD | Price to earnings Ratio 16.34 | 1Y Target Price - |
Price to earnings Ratio 16.34 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.41 | 52 Weeks Range 9.68 - 26.32 | Updated Date 06/29/2025 |
52 Weeks Range 9.68 - 26.32 | Updated Date 06/29/2025 | ||
Dividends yield (FY) 2.88% | Basic EPS (TTM) 1.02 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 17.14% | Operating Margin (TTM) 25.62% |
Management Effectiveness
Return on Assets (TTM) 17.13% | Return on Equity (TTM) 72.69% |
Valuation
Trailing PE 16.34 | Forward PE - | Enterprise Value 442535968 | Price to Sales(TTM) 2.69 |
Enterprise Value 442535968 | Price to Sales(TTM) 2.69 | ||
Enterprise Value to Revenue 3.13 | Enterprise Value to EBITDA 10.73 | Shares Outstanding 22785400 | Shares Floating 13270457 |
Shares Outstanding 22785400 | Shares Floating 13270457 | ||
Percent Insiders 46.97 | Percent Institutions 51.25 |
Upturn AI SWOT
National Research Corp
Company Overview
History and Background
National Research Corporation (NRC) was founded in 1981. It initially focused on healthcare performance measurement and has evolved into a leading provider of analytics and insights that help healthcare organizations improve patient experience, engagement, and financial performance.
Core Business Areas
- Experience Solutions: Patient experience measurement and improvement solutions, including surveys, real-time feedback, and advisory services. Focuses on improving patient satisfaction, loyalty, and outcomes.
- Governance Solutions: Solutions to help healthcare organizations monitor quality, safety, and risk. Provides data and insights to support board and executive decision-making.
- Market Insights: Market research and analytics services that help healthcare organizations understand consumer preferences, competitive dynamics, and market trends.
Leadership and Structure
Michael Hays is the CEO. The company has a typical corporate structure with departments for sales, marketing, product development, finance, and operations.
Top Products and Market Share
Key Offerings
- Market Share (%): 25
- Patient Experience Measurement: Surveys and data analytics tools to measure patient satisfaction and identify areas for improvement. NRC is a leading provider in this space, estimated 25% market share in the healthcare patient survey area. Competitors include Press Ganey, Advisory Board, and Kaufman Hall.
- Market Share (%): 1
- Transparency Dashboards: Software and dashboards that provide real-time visibility into patient feedback and performance metrics. Unknown market share. Competitors include Qualtrics and Medallia
- Market Insights and Strategy: Market research and data analytics to improve targeting, grow revenue, and differentiate services. Unknown market share. Competitors include Definitive Healthcare, Trilliant Health, and Sg2
- Market Share (%): 5
Market Dynamics
Industry Overview
The healthcare analytics market is growing due to increasing pressure to improve patient outcomes, reduce costs, and comply with regulations. Data analytics helps healthcare organizations better understand patients, manage operations, and improve financial performance.
Positioning
NRC is a well-established player in the healthcare analytics market, particularly in patient experience measurement. Its competitive advantages include its deep industry expertise, comprehensive data assets, and strong relationships with healthcare providers.
Total Addressable Market (TAM)
The Total Addressable Market (TAM) for healthcare analytics is estimated to be $30 Billion and NRC is positioned to grow its presence in a fragmented and growing market.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Deep industry expertise
- Comprehensive data assets
- Established relationships with healthcare providers
- Recurring revenue model
Weaknesses
- Relatively small company size
- Dependence on the healthcare industry
- Potential for disruption from new technologies
Opportunities
- Expanding into new healthcare segments
- Developing new analytics solutions
- Leveraging artificial intelligence and machine learning
- Acquiring complementary businesses
- International Expansion
Threats
- Increased competition
- Changing healthcare regulations
- Economic downturn
- Data security breaches
Competitors and Market Share
Key Competitors
- PGND
- ADVY
- MDSO
Competitive Landscape
National Research Corp competes with larger and more diversified healthcare technology companies. NRC's advantage lies in its deep focus on patient experience and its strong relationships with healthcare providers.
Growth Trajectory and Initiatives
Historical Growth: National Research Corp has experienced slow but steady growth in recent years.
Future Projections: Analysts project moderate revenue growth in the coming years, driven by increasing demand for healthcare analytics.
Recent Initiatives: Focusing on new product development, expanding market reach and strategic partnerships.
Summary
National Research Corp is a well-established player in the healthcare analytics market, with a strong focus on patient experience. It has a solid reputation and recurring revenue, but its growth is relatively slow. It faces competition from larger players and needs to innovate to maintain its market position.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Website
- Market Research Reports
- Analyst Estimates
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Market share estimates are approximate and based on publicly available information.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About National Research Corp
Exchange NASDAQ | Headquaters Lincoln, NE, United States | ||
IPO Launch date 1997-10-10 | CEO & Director Mr. Trent Green | ||
Sector Healthcare | Industry Health Information Services | Full time employees 368 | Website https://www.nrchealth.com |
Full time employees 368 | Website https://www.nrchealth.com | ||
National Research Corporation provides analytics and insights that facilitate measurement and improvement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company also offers marketing experience solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools through a multi-mode digital platform. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; employee experience solutions that give care teams information, tools and support needed to create engagement and open communication throughout the employee lifecycle; and consumer experience solutions which capture feedback across the healthcare journey, drive choice to build volume, and co-design experiences and services through community insights. Additionally, the company offers Huey AI, an AI engine for Human Understanding that serves as a healthcare experience management companion; and governance solutions for not-for-profit health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.